|4.14|| +0.09 / +2.22%|
Bacterin International Holdings, Inc. develops bioactive coatings for medical applications and revolutionary bone graft material, processes and markets innovative, biologic allograft for transplantation. Its products are used in applications, including enhancing fusion in spine surgery, relief of back pain with a facet joint stabilization, promotion of bone growth in foot and ankle surgery, promotion of skull healing following neurosurgery and subcondral bone defect repair in knee and other joint surgeries. The company's Bacterin's Medical Device and Coatings division focuses on the development of bioactive coating technologies for implantable device. It also manages surgical kits necessary to support this implantation of products. The company was founded by Guy S. Cook in 1998 and is headquartered in Belgrade, MT.
|Daniel S. Goldberger||President, Chief Executive Officer & Director|
|Darrel L. Holmes||Chief Operating Officer|
|John P. Gandolfo||Chief Financial Officer, Secretary & Treasurer|
|Gregory A. Juda||Chief Scientific Officer|
|Jill Gilpin||General Counsel|